MBX Competitors & Alternatives
Compare MBX Biosciences, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MBX
Main Stock$57.80
Tradestie Score
53
Market Cap
$800.41M
Analyst Upside
+19.5%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$33.47
|
$2.89B | - | 56 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$38.79
|
$2.85B | - | 61 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.45
|
$2.56B | 18.2 | 57 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$34.79
|
$2.44B | - | 62 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$65.44
|
$2.42B | - | 63 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$146.63
|
$2.41B | - | 58 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$37.65
|
$2.40B | - | 60 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
More MBX Analysis
Data updated: Jul 05, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry